| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 18 | 2013 | 401 | 1.560 |
Why?
|
| Patient Participation | 4 | 2023 | 124 | 1.430 |
Why?
|
| Colorectal Neoplasms | 10 | 2025 | 642 | 1.420 |
Why?
|
| Aged | 37 | 2025 | 6223 | 1.180 |
Why?
|
| Reminder Systems | 6 | 2025 | 76 | 1.130 |
Why?
|
| Emergency Service, Hospital | 7 | 2025 | 402 | 1.090 |
Why?
|
| Humans | 66 | 2026 | 17622 | 1.020 |
Why?
|
| Electronic Health Records | 8 | 2025 | 719 | 1.010 |
Why?
|
| Social Isolation | 2 | 2025 | 20 | 0.980 |
Why?
|
| Occult Blood | 6 | 2025 | 162 | 0.950 |
Why?
|
| Dental Care | 3 | 2015 | 15 | 0.910 |
Why?
|
| Early Detection of Cancer | 7 | 2025 | 559 | 0.910 |
Why?
|
| Middle Aged | 48 | 2025 | 7954 | 0.910 |
Why?
|
| Medicare | 2 | 2025 | 197 | 0.900 |
Why?
|
| Male | 52 | 2026 | 10014 | 0.880 |
Why?
|
| Needs Assessment | 1 | 2025 | 66 | 0.870 |
Why?
|
| Female | 56 | 2026 | 12715 | 0.870 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2025 | 689 | 0.790 |
Why?
|
| Adult | 35 | 2026 | 7621 | 0.660 |
Why?
|
| Retrospective Studies | 19 | 2022 | 2502 | 0.630 |
Why?
|
| Surveys and Questionnaires | 13 | 2025 | 1296 | 0.610 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2020 | 540 | 0.590 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2019 | 380 | 0.580 |
Why?
|
| Ambulatory Care | 2 | 2019 | 228 | 0.570 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 45 | 0.570 |
Why?
|
| Primary Health Care | 4 | 2019 | 729 | 0.540 |
Why?
|
| Opioid-Related Disorders | 1 | 2020 | 185 | 0.530 |
Why?
|
| Quality of Life | 8 | 2010 | 505 | 0.530 |
Why?
|
| United States | 16 | 2025 | 3922 | 0.520 |
Why?
|
| Aged, 80 and over | 11 | 2025 | 1976 | 0.500 |
Why?
|
| Referral and Consultation | 2 | 2020 | 161 | 0.500 |
Why?
|
| Feces | 3 | 2025 | 89 | 0.490 |
Why?
|
| Mass Screening | 4 | 2025 | 693 | 0.490 |
Why?
|
| Datasets as Topic | 1 | 2015 | 19 | 0.470 |
Why?
|
| Preventive Health Services | 2 | 2015 | 147 | 0.450 |
Why?
|
| Cross-Sectional Studies | 13 | 2026 | 1295 | 0.450 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2014 | 9 | 0.440 |
Why?
|
| Social Support | 2 | 2025 | 215 | 0.420 |
Why?
|
| Professional-Family Relations | 1 | 2013 | 52 | 0.400 |
Why?
|
| Telephone | 3 | 2012 | 159 | 0.390 |
Why?
|
| Quality Improvement | 2 | 2015 | 189 | 0.380 |
Why?
|
| Family | 1 | 2013 | 111 | 0.380 |
Why?
|
| Intensive Care Units | 1 | 2013 | 105 | 0.380 |
Why?
|
| Logistic Models | 7 | 2019 | 866 | 0.380 |
Why?
|
| Loneliness | 2 | 2022 | 10 | 0.380 |
Why?
|
| Communication | 1 | 2013 | 181 | 0.370 |
Why?
|
| Self Care | 3 | 2009 | 144 | 0.370 |
Why?
|
| Patient Satisfaction | 4 | 2015 | 193 | 0.360 |
Why?
|
| Social Determinants of Health | 2 | 2024 | 39 | 0.350 |
Why?
|
| Adolescent | 15 | 2026 | 3625 | 0.350 |
Why?
|
| Chronic Disease | 6 | 2023 | 398 | 0.350 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2020 | 308 | 0.340 |
Why?
|
| Medicaid | 3 | 2011 | 188 | 0.340 |
Why?
|
| Young Adult | 6 | 2026 | 2538 | 0.330 |
Why?
|
| Prescription Drugs | 1 | 2010 | 30 | 0.320 |
Why?
|
| Data Collection | 5 | 2014 | 234 | 0.300 |
Why?
|
| Oregon | 6 | 2026 | 172 | 0.300 |
Why?
|
| Health Maintenance Organizations | 6 | 2015 | 403 | 0.300 |
Why?
|
| Decision Support Techniques | 3 | 2020 | 88 | 0.300 |
Why?
|
| Electronic Mail | 1 | 2009 | 51 | 0.300 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2021 | 187 | 0.290 |
Why?
|
| Outcome Assessment (Health Care) | 4 | 2015 | 213 | 0.290 |
Why?
|
| Continental Population Groups | 1 | 2010 | 283 | 0.290 |
Why?
|
| Temporal Arteries | 1 | 2007 | 1 | 0.270 |
Why?
|
| Giant Cell Arteritis | 1 | 2007 | 1 | 0.270 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2007 | 1 | 0.270 |
Why?
|
| Managed Care Programs | 4 | 2012 | 300 | 0.270 |
Why?
|
| Biopsy | 1 | 2007 | 80 | 0.270 |
Why?
|
| Breast Neoplasms | 3 | 2025 | 1005 | 0.260 |
Why?
|
| Unnecessary Procedures | 2 | 2017 | 21 | 0.250 |
Why?
|
| Video Recording | 1 | 2025 | 15 | 0.230 |
Why?
|
| Northwestern United States | 4 | 2019 | 53 | 0.230 |
Why?
|
| Health Services Accessibility | 4 | 2011 | 269 | 0.230 |
Why?
|
| Text Messaging | 1 | 2025 | 38 | 0.220 |
Why?
|
| Hospitalization | 5 | 2025 | 831 | 0.220 |
Why?
|
| Communication Barriers | 1 | 2004 | 29 | 0.210 |
Why?
|
| Postoperative Complications | 2 | 2008 | 99 | 0.210 |
Why?
|
| Patient Selection | 1 | 2005 | 181 | 0.210 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2004 | 10 | 0.210 |
Why?
|
| Renal Replacement Therapy | 2 | 2021 | 8 | 0.210 |
Why?
|
| Venous Thrombosis | 1 | 2004 | 23 | 0.210 |
Why?
|
| Cohort Studies | 5 | 2021 | 2502 | 0.210 |
Why?
|
| Health Status | 4 | 2011 | 291 | 0.200 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2010 | 67 | 0.200 |
Why?
|
| Child Health Services | 1 | 2004 | 107 | 0.200 |
Why?
|
| Glomerular Filtration Rate | 2 | 2021 | 158 | 0.200 |
Why?
|
| Memory Disorders | 1 | 2022 | 8 | 0.190 |
Why?
|
| Length of Stay | 2 | 2012 | 182 | 0.190 |
Why?
|
| Obesity | 1 | 2008 | 821 | 0.180 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2002 | 3 | 0.180 |
Why?
|
| Infant Welfare | 1 | 2002 | 4 | 0.180 |
Why?
|
| Maternal Welfare | 1 | 2002 | 12 | 0.180 |
Why?
|
| Demography | 2 | 2020 | 92 | 0.180 |
Why?
|
| Oral Health | 1 | 2021 | 17 | 0.180 |
Why?
|
| Neoplasms | 1 | 2026 | 457 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 319 | 0.170 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2020 | 2 | 0.160 |
Why?
|
| Age Factors | 3 | 2012 | 874 | 0.160 |
Why?
|
| Kidney | 1 | 2020 | 52 | 0.160 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 23 | 0.160 |
Why?
|
| Analgesics, Opioid | 2 | 2020 | 258 | 0.160 |
Why?
|
| Carotid Artery Diseases | 1 | 2019 | 11 | 0.150 |
Why?
|
| Sickness Impact Profile | 3 | 2008 | 25 | 0.150 |
Why?
|
| Patient Education as Topic | 2 | 2009 | 193 | 0.140 |
Why?
|
| Prospective Studies | 5 | 2019 | 1251 | 0.140 |
Why?
|
| HIV Infections | 3 | 2000 | 584 | 0.140 |
Why?
|
| Confidence Intervals | 3 | 2011 | 228 | 0.140 |
Why?
|
| Coronary Artery Disease | 1 | 2019 | 112 | 0.140 |
Why?
|
| Insurance, Health | 1 | 2019 | 169 | 0.140 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 452 | 0.140 |
Why?
|
| Central Venous Catheters | 1 | 2018 | 3 | 0.140 |
Why?
|
| Hemoglobins | 1 | 2018 | 37 | 0.140 |
Why?
|
| Catheterization, Central Venous | 1 | 2018 | 10 | 0.140 |
Why?
|
| Proteinuria | 1 | 2018 | 26 | 0.130 |
Why?
|
| Depression | 1 | 2022 | 507 | 0.130 |
Why?
|
| Child, Preschool | 5 | 2016 | 1455 | 0.130 |
Why?
|
| Renal Dialysis | 1 | 2018 | 57 | 0.130 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2017 | 19 | 0.130 |
Why?
|
| Health Care Surveys | 2 | 2010 | 210 | 0.130 |
Why?
|
| Vitamin D Deficiency | 1 | 2017 | 24 | 0.130 |
Why?
|
| Treatment Outcome | 5 | 2016 | 1161 | 0.130 |
Why?
|
| Guideline Adherence | 2 | 2015 | 155 | 0.130 |
Why?
|
| Patient Admission | 2 | 2012 | 69 | 0.130 |
Why?
|
| Patient-Centered Care | 3 | 2007 | 190 | 0.130 |
Why?
|
| Anti-Asthmatic Agents | 5 | 2013 | 88 | 0.130 |
Why?
|
| Risk Factors | 7 | 2026 | 3291 | 0.130 |
Why?
|
| Vitamin D | 1 | 2017 | 76 | 0.120 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 149 | 0.120 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2006 | 33 | 0.120 |
Why?
|
| Adenoidectomy | 1 | 2016 | 1 | 0.120 |
Why?
|
| Tonsillectomy | 1 | 2016 | 1 | 0.120 |
Why?
|
| Pain, Postoperative | 1 | 2016 | 16 | 0.120 |
Why?
|
| Clinical Protocols | 1 | 2016 | 39 | 0.120 |
Why?
|
| Body Mass Index | 2 | 2012 | 959 | 0.120 |
Why?
|
| Pain Management | 1 | 2016 | 58 | 0.120 |
Why?
|
| Propensity Score | 1 | 2015 | 80 | 0.110 |
Why?
|
| Child | 5 | 2016 | 2485 | 0.110 |
Why?
|
| Quality Assurance, Health Care | 1 | 2015 | 120 | 0.110 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 42 | 0.110 |
Why?
|
| Patient Outcome Assessment | 1 | 2015 | 27 | 0.110 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 148 | 0.110 |
Why?
|
| Socioeconomic Factors | 3 | 2026 | 603 | 0.110 |
Why?
|
| Postal Service | 1 | 2014 | 72 | 0.100 |
Why?
|
| Population Surveillance | 1 | 2015 | 248 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 545 | 0.100 |
Why?
|
| Quality of Health Care | 2 | 2007 | 260 | 0.100 |
Why?
|
| Controlled Before-After Studies | 1 | 2013 | 4 | 0.100 |
Why?
|
| Checklist | 1 | 2013 | 13 | 0.100 |
Why?
|
| Point-of-Care Systems | 1 | 2013 | 8 | 0.100 |
Why?
|
| Continuity of Patient Care | 1 | 2015 | 95 | 0.100 |
Why?
|
| Outcome and Process Assessment (Health Care) | 1 | 2013 | 96 | 0.100 |
Why?
|
| Odds Ratio | 3 | 2018 | 631 | 0.100 |
Why?
|
| Time Factors | 5 | 2020 | 1038 | 0.090 |
Why?
|
| Physicians, Primary Care | 1 | 2013 | 63 | 0.090 |
Why?
|
| Dental Prophylaxis | 1 | 2012 | 1 | 0.090 |
Why?
|
| Periodontal Diseases | 1 | 2012 | 1 | 0.090 |
Why?
|
| Periodontal Index | 1 | 2012 | 1 | 0.090 |
Why?
|
| Perioperative Care | 1 | 2012 | 4 | 0.090 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 168 | 0.090 |
Why?
|
| Pharmacists | 1 | 2012 | 50 | 0.090 |
Why?
|
| Hypoglycemia | 1 | 2012 | 48 | 0.090 |
Why?
|
| State Health Plans | 1 | 2011 | 32 | 0.090 |
Why?
|
| Cholesterol, LDL | 1 | 2012 | 117 | 0.080 |
Why?
|
| Inpatients | 1 | 2011 | 78 | 0.080 |
Why?
|
| Program Evaluation | 2 | 2015 | 214 | 0.080 |
Why?
|
| Infant, Newborn | 2 | 2004 | 842 | 0.080 |
Why?
|
| Linear Models | 1 | 2010 | 204 | 0.080 |
Why?
|
| Self Report | 1 | 2011 | 262 | 0.080 |
Why?
|
| Health Care Costs | 1 | 2011 | 211 | 0.080 |
Why?
|
| Sex Factors | 1 | 2012 | 599 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 144 | 0.080 |
Why?
|
| ROC Curve | 3 | 2018 | 73 | 0.080 |
Why?
|
| Predictive Value of Tests | 4 | 2015 | 346 | 0.070 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2006 | 67 | 0.070 |
Why?
|
| Health Services | 2 | 2011 | 110 | 0.070 |
Why?
|
| Health Status Disparities | 1 | 2010 | 151 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2012 | 1107 | 0.070 |
Why?
|
| Podiatry | 1 | 2008 | 2 | 0.070 |
Why?
|
| Foot | 1 | 2008 | 4 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 1157 | 0.070 |
Why?
|
| Psychometrics | 2 | 2007 | 119 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 702 | 0.070 |
Why?
|
| Venous Thromboembolism | 1 | 2008 | 55 | 0.070 |
Why?
|
| California | 4 | 2025 | 2433 | 0.070 |
Why?
|
| Ethnic Groups | 1 | 2010 | 443 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2007 | 23 | 0.060 |
Why?
|
| Infant | 2 | 2016 | 1228 | 0.060 |
Why?
|
| Self Concept | 1 | 2006 | 39 | 0.060 |
Why?
|
| Disease Progression | 2 | 2020 | 266 | 0.060 |
Why?
|
| Clinical Pharmacy Information Systems | 1 | 2006 | 10 | 0.060 |
Why?
|
| Albuterol | 1 | 2006 | 7 | 0.060 |
Why?
|
| Pharmaceutical Services | 1 | 2006 | 36 | 0.060 |
Why?
|
| Allergy and Immunology | 1 | 2005 | 5 | 0.060 |
Why?
|
| Registries | 2 | 2020 | 475 | 0.060 |
Why?
|
| Databases as Topic | 1 | 2005 | 19 | 0.060 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2005 | 16 | 0.060 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 32 | 0.060 |
Why?
|
| Area Under Curve | 2 | 2018 | 34 | 0.060 |
Why?
|
| Washington | 1 | 2026 | 388 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2013 | 363 | 0.050 |
Why?
|
| Spatial Analysis | 1 | 2024 | 11 | 0.050 |
Why?
|
| Community Networks | 1 | 2024 | 21 | 0.050 |
Why?
|
| Language | 1 | 2004 | 52 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 350 | 0.050 |
Why?
|
| Thromboembolism | 1 | 2004 | 32 | 0.050 |
Why?
|
| Mammography | 2 | 2015 | 173 | 0.050 |
Why?
|
| Prevalence | 1 | 2026 | 830 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 527 | 0.050 |
Why?
|
| Severity of Illness Index | 4 | 2006 | 446 | 0.050 |
Why?
|
| Interviews as Topic | 2 | 2015 | 324 | 0.050 |
Why?
|
| Utah | 1 | 2002 | 38 | 0.040 |
Why?
|
| Perinatal Care | 1 | 2002 | 12 | 0.040 |
Why?
|
| Postnatal Care | 1 | 2002 | 20 | 0.040 |
Why?
|
| Minority Groups | 1 | 2022 | 104 | 0.040 |
Why?
|
| Probability | 1 | 2002 | 70 | 0.040 |
Why?
|
| Colonoscopy | 2 | 2015 | 265 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2002 | 37 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2002 | 137 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 100 | 0.040 |
Why?
|
| Health Surveys | 3 | 2007 | 242 | 0.040 |
Why?
|
| Insurance Claim Review | 2 | 2011 | 49 | 0.040 |
Why?
|
| Anxiety | 1 | 2022 | 162 | 0.040 |
Why?
|
| HIV Long-Term Survivors | 1 | 2000 | 2 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 33 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2002 | 154 | 0.040 |
Why?
|
| Patient Readmission | 1 | 2002 | 163 | 0.040 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 2 | 0.040 |
Why?
|
| Urban Health Services | 1 | 1998 | 11 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 609 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 383 | 0.030 |
Why?
|
| Los Angeles | 1 | 1998 | 150 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 302 | 0.030 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2017 | 55 | 0.030 |
Why?
|
| Pregnancy | 1 | 2002 | 1565 | 0.030 |
Why?
|
| Health Status Indicators | 2 | 2008 | 60 | 0.030 |
Why?
|
| Codeine | 1 | 2016 | 2 | 0.030 |
Why?
|
| Community Health Services | 1 | 1996 | 78 | 0.030 |
Why?
|
| Group Practice | 1 | 2016 | 21 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 1093 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 10 | 0.030 |
Why?
|
| Mid-Atlantic Region | 1 | 2015 | 6 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2015 | 43 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 50 | 0.030 |
Why?
|
| Medical Records | 1 | 2015 | 91 | 0.030 |
Why?
|
| Program Development | 1 | 2015 | 65 | 0.030 |
Why?
|
| Survivors | 1 | 2015 | 157 | 0.030 |
Why?
|
| Databases, Factual | 2 | 2006 | 304 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 215 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2013 | 20 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2015 | 290 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 208 | 0.020 |
Why?
|
| Professional Role | 1 | 2012 | 14 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 2012 | 16 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 237 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 80 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 686 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 323 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2012 | 107 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 492 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2012 | 319 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2009 | 69 | 0.020 |
Why?
|
| Colorado | 1 | 2007 | 170 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2008 | 214 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2007 | 84 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2007 | 119 | 0.020 |
Why?
|
| Pacific States | 1 | 2006 | 3 | 0.020 |
Why?
|
| Specialization | 1 | 2005 | 21 | 0.010 |
Why?
|
| Pulmonary Medicine | 1 | 2005 | 19 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 2005 | 35 | 0.010 |
Why?
|
| Comorbidity | 1 | 2007 | 552 | 0.010 |
Why?
|
| Emotions | 1 | 2005 | 34 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2005 | 123 | 0.010 |
Why?
|
| Self Disclosure | 1 | 1996 | 19 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1996 | 142 | 0.010 |
Why?
|